Back to the records

Study

An Integrative Review of Scientific Evidence for Reconnective Healing.

Ann L Baldwin, Natalie L Trent · Journal of alternative and complementary medicine (New York, N.Y.) · 2017

Read the original paper ↗

The short version

This integrative review gathered every peer-reviewed study of Reconnective Healing — a biofield therapy (energy healing working with the field proposed to surround and permeate the body) in which the practitioner's hands typically stay off the body, often at growing distances. Despite worldwide training programs, only five qualifying studies existed, covering 197 measured participants. The authors searched five scientific databases, applied 18 quality criteria adapted from clinical-trial reporting standards, and scored every study independently (average quality 76%). The five studies ranged widely: a single-patient case report, two studies using electrodermal and gas-discharge-visualization (GDV) instruments, a physiological study of practitioners themselves, and one randomized placebo-controlled trial. The trial is the headline. Seventy-eight people with painful shoulder limitations were randomized to Reconnective Healing, Reiki, sham healing, physical therapy, or rest. After one 10-minute session, RH improved arm range of motion by 26 degrees on average — more than Reiki (20°) or physical therapy (12°), and far more than rest (3°) — with a large effect size (0.8, a substantial difference between groups). Pain dropped 24% after RH. Crucially, fake "sham" healing produced no significant improvement, which weakens a placebo explanation. Elsewhere, practitioners in a healing state showed measurably increased finger blood flow (p = 0.003), and a 74-year-old who had needed a walker for six months walked unaided after three sessions — though that single case had no controls at all. The review is honest about the limits: several studies used instruments that have never been properly validated, designs were too different to combine, and both review authors have published RH research themselves, including the trial reviewed. The fair reading: one well-designed trial suggests short-term benefit for shoulder mobility and pain, everything else is preliminary, and replication with follow-up is the necessary next step.

Key findings

  • Reconnective Healing is a hands-off biofield therapy in which practitioners report sensations that strengthen as their hands move farther from the recipient's body.
  • Only five peer-reviewed studies existed as of this review, covering 197 measured participants — a very small evidence base for a globally taught practice.
  • In the one randomized placebo-controlled trial (78 people), a single 10-minute session improved shoulder range of motion by 26 degrees and cut pain 24%, outperforming Reiki, brief physical therapy, and sham healing.
  • Sham healing produced no significant improvement, which argues against a pure placebo explanation for the shoulder results.
  • Several supporting studies relied on GDV and AMI devices whose measurements have not been scientifically validated, and the review's authors include the RCT's own lead investigator — reasons for cautious reading.

Common questions

What healing modality was studied?

Reconnective Healing — a hands-off biofield therapy developed by Eric Pearl in the early 1990s — reviewed across all five peer-reviewed studies published by mid-2016, with Reiki as a comparator in two.

What condition was addressed?

Painful shoulder limitation in the key randomized trial; the other studies measured physiological arousal in healthy volunteers, practitioners, and one mobility-impaired case-study patient.

What were the main findings?

One 10-minute RH session improved shoulder range of motion by 26° (effect size 0.8) and reduced pain 24%, beating Reiki, brief physical therapy, and sham; practitioner studies showed measurable autonomic changes; GDV/EDA studies showed increased arousal on unvalidated instruments.

How strong is the evidence?

Mixed: one good randomized placebo-controlled trial supports short-term shoulder benefit, but the overall base is five heterogeneous studies, several using unvalidated devices, with author overlap between the review and the RCT.

What are the clinical implications?

RH may offer a safe, brief, non-pharmacologic option for painful shoulder limitation pending replication with follow-up; no general effectiveness claim is supported.

This summary and its findings were generated by AI from the published paper and may contain imperfections. It describes a study and is not medical advice — talk to a qualified clinician about your own health (terms). The original study is always the source of truth — read it above.